While much of the energy in the drug pipeline has centered on orphan drugs, novel therapies in more crowded markets have also been marching toward approval, according to a new report from Optum.

AHIP said that a proposed requirement for insurers to offer standardized plan options on the exchanges would “stifle innovation” and includes provisions that would be hard for payers to roll out, such as common drug formulary designs.

Although still up from last year, CEO Sam Hazen said that the omicron surge began hitting HCA’s bottom line in early December. Alongside quarterly earnings, the 183-hospital system announced its 2022 guidance and new plans to build five new hospitals in Texas.

The number of ACOs in the Medicare Shared Savings Program increased modestly to 483, which advocates say is a major warning sign for the program.